Funds · TRDA

Who owns TRDA?

Institutional ownership of Entrada Therapeutics Inc. from Form 13F, Q2 2026

129 institutional managers reported holding Entrada Therapeutics Inc. (TRDA) in Form 13F filings for Q2 2026, with 29,445,455 shares worth $217M. The largest reported holder was Baker Bros. Advisors LP. Managers that filed both quarters added a net 3,974,963 shares (+15.6%). 27 opened new positions and 16 sold out.

Funds holding
129
Value held
$217M
New / sold out
27 / 16
Net shares, same filers
+15.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of TRDA

FundValueShare of 13F holdingsSharesMove
Baker Bros. Advisors LP$37.3M17.2%5,072,730Unchanged
5AM Venture Management, LLC$29.9M13.8%4,056,379Unchanged
BlackRock, Inc.$19.0M8.8%2,583,333Added
Merck & Co., Inc.$12.8M5.9%1,739,768New
Vanguard Capital Management LLC$9.3M4.3%1,269,634Added
MPM Bioimpact LLC$9.2M4.3%1,253,053New
TCG Crossover Management, LLC$7.8M3.6%1,060,230Trimmed
Wellington Management Group LLP$7.0M3.2%954,419Trimmed
Millennium Management LLC$5.6M2.6%763,959Added
StepStone Group LP$5.6M2.6%761,277Unchanged
Geode Capital Management, LLC$5.3M2.4%717,430Added
AQR Capital Management LLC$5.1M2.4%699,537Added
Nantahala Capital Management, LLC$4.4M2.0%601,150Added
State Street Corp$4.4M2.0%596,677Added
Price T Rowe Associates Inc$4.0M1.8%542,316Added
JPMorgan Chase & Co$3.8M1.7%496,457Added
Acadian Asset Management LLC$2.9M1.4%400,862Added
Citadel Advisors LLC$2.9M1.3%394,323Added
Dimensional Fund Advisors LP$2.8M1.3%376,136Added
Northern Trust Corp$2.3M1.1%309,942Added
Jacobs Levy Equity Management, Inc$2.2M1.0%303,459Trimmed
Vanguard Portfolio Management LLC$1.9M0.9%254,130Added
Charles Schwab Investment Management Inc$1.5M0.7%197,136Trimmed
Longaeva Partners L.P.$1.4M0.7%195,237Trimmed
Morgan Stanley$1.4M0.7%191,650Added

Share of 13F holdings is each fund's shares as a share of the 29,445,455 TRDA shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Merck & Co., Inc. New+$12.8M
  2. MPM Bioimpact LLC New+$9.2M
  3. AQR Capital Management LLC Added+$4.6M
  4. JPMorgan Chase & Co Added+$3.7M
  5. Nantahala Capital Management, LLC Added+$3.3M
  6. Millennium Management LLC Added+$1.8M
  7. BlackRock, Inc. Added+$1.7M
  8. Citadel Advisors LLC Added+$1.3M
  9. Quantinno Capital Management LP Added+$867K
  10. Gsa Capital Partners LLP New+$648K

Biggest sellers in Q2 2026

  1. TCG Crossover Management, LLC Trimmed-$9.0M
  2. Jones Hill Capital LP Sold out-$4.7M
  3. Acuta Capital Partners, LLC Sold out-$1.1M
  4. Nuveen, LLC Trimmed-$875K
  5. Marshall Wace, LLP Sold out-$679K
  6. BNP Paribas Financial Markets Trimmed-$634K
  7. Wellington Management Group LLP Trimmed-$591K
  8. Woodline Partners LP Trimmed-$518K
  9. Jane Street Group, LLC Sold out-$470K
  10. D. E. Shaw & Co., Inc. Trimmed-$343K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $48.6M and sold $22.7M; 55 added and 31 trimmed.

Schedule 13D and 13G filings on TRDA

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about TRDA ownership

Who owns TRDA stock?
129 institutional investment managers reported TRDA positions in their Form 13F filings for Q2 2026, holding 29,445,455 shares worth $217M in total. Baker Bros. Advisors LP reported the largest position.
Are funds buying or selling TRDA?
In Q2 2026, 27 managers opened new TRDA positions, 55 added, 31 trimmed and 16 sold out. Managers that filed in both quarters added a net 3,974,963 shares.
How current is this TRDA institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TRDA by CUSIP. Options are left out. TRDA news and filings · TRDA insider trades · Top funds